Lechin F, van der Dijs B, Jackubowicz D, Camero R E, Lechin S, Villa S, Reinfeld B, Lechin M E
Psychoneuroendocrinology. 1987;12(2):117-29. doi: 10.1016/0306-4530(87)90042-4.
Systolic blood pressure (SBP), diastolic blood pressure (DBP), and plasma norepinephrine (NE), cortisol (CRT), growth hormone (GH) and prolactin (PRL) were studied before and after clonidine (2.5 micrograms/kg i.m.) administration in 193 chronic severely ill patients and 193 normal subjects matched by age and sex. During exacerbation periods (positive manifestations of impairment and progressive disease), the patients showed higher NE, CRT and DBP than the normals or when they were investigated during non-exacerbation periods (92 of the 193). Clonidine induced sharp, marked reductions of NE, CRT and DBP, plus a sudden increase of GH, in all the patients during exacerbation periods. Non-significant reductions of NE, CRT and DBP were observed in normals and in patients during non-exacerbation periods. On the other hand, the GH increase registered during exacerbation periods was of an order of magnitude higher than that registered in normals and in patients during non-exacerbation periods. Significant reduction of SBP was registered both in normals and patients (exacerbation and non-exacerbation periods). Some tendency to PRL lowering was observed during exacerbation periods only. A high positive correlation between NE and DBP (pre- and post-clonidine values) was obtained during exacerbation periods in patients, but not in normals or during non-exacerbation periods in the patients. Similarly, a close negative correlation was obtained between CRT and GH (postclonidine values) during exacerbation periods, but not in normals or during non-exacerbation periods. No significant correlation was found between NE and SBP in any group of subjects. The clonidine-induced changes in GH and CRT observed in the patients during exacerbation periods were in striking contrast to the absence of these changes in depressed patients. This finding is consistent with the low rate of depression (6.7%) registered among our patients during exacerbation periods. The high plasma NE and CRT levels registered in chronic severely ill patients during exacerbation periods reflect a central and peripheral sympathetic hyperactivity, accompanied by an overactivity of the pituitary--adrenocortical axis. The strong reduction of DBP, NE and CRT, along with the sharp and great increase of GH, might be useful as indicators in assessing the exacerbation and progression of severe chronic illnesses.
在193例慢性重症患者和193例年龄及性别相匹配的正常受试者中,研究了可乐定(2.5微克/千克,肌肉注射)给药前后的收缩压(SBP)、舒张压(DBP)以及血浆去甲肾上腺素(NE)、皮质醇(CRT)、生长激素(GH)和催乳素(PRL)。在病情加重期(出现功能损害和疾病进展的阳性表现),患者的NE、CRT和DBP高于正常受试者,或高于他们在非加重期(193例中的92例)接受检查时的水平。在病情加重期,可乐定使所有患者的NE、CRT和DBP急剧、显著降低,同时使GH突然升高。在正常受试者和非加重期的患者中,观察到NE、CRT和DBP有不显著的降低。另一方面,病情加重期记录到的GH升高幅度高于正常受试者和非加重期患者。正常受试者和患者(加重期和非加重期)的SBP均有显著降低。仅在病情加重期观察到PRL有降低的趋势。在患者的病情加重期,NE与DBP(可乐定给药前后的值)之间存在高度正相关,但在正常受试者或患者的非加重期不存在这种相关性。同样,在病情加重期,CRT与GH(可乐定给药后的值)之间存在密切的负相关,但在正常受试者或患者的非加重期不存在这种相关性。在任何一组受试者中,均未发现NE与SBP之间存在显著相关性。在病情加重期患者中观察到的可乐定诱导的GH和CRT变化,与抑郁症患者中未出现这些变化形成鲜明对比。这一发现与我们的患者在病情加重期抑郁症发生率较低(6.7%)是一致的。慢性重症患者在病情加重期血浆NE和CRT水平升高,反映了中枢和外周交感神经活动亢进,同时伴有垂体 - 肾上腺皮质轴活动过度。DBP、NE和CRT的强烈降低,以及GH的急剧大幅升高,可能作为评估严重慢性疾病加重和进展的指标。